Views

CrossRef citations to date

Altmetric

ORIGINAL ARTICLES: MEDICAL ONCOLOGY

Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis

Asmaa M. ZahranDepartment of Clinical Pathology, South Egypt Cancer Institute, Assiut, Egypt;

Mona H. Abdel-RahimDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt;

Ahmed RefaatMedical Oncology, South Egypt Cancer Institute, Assiut, Egypt;

Mona SayedRadiotherapy Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt;

Mostafa M. OthmanRadiodiagnosis Department, Faculty of Medicine, Assiut University, Assiut, Egypt;

Lamiaa M. R. KhalakRadiodiagnosis Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt;

Helal F. HettaDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut, Egypt; ;Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH, USACorrespondence[email protected] [email protected]

http://orcid.org/0000-0001-8541-7304

show all

Figures & data

Figure 1. Flow cytometric detection of the circulating hematopoietic stem cell (HSCs), and the circulating endothelial progenitor cells (EPCs). (A) The analysis gate (R1) included CD45⁻ cells. (B) The expression of CD34 and CD133 was assessed on CD45⁻ cells to detect hematopoietic stem cells (HSCs). (C) Then, the expression of CD144 on hematopoietic stem cells (HSCs) was assessed to detect endothelial progenitor cells (EPCs).

Figure 2. Flow cytometric detection of circulating cancer stem cells. (A) The CD45⁻ cells (R1) were selected. (B) The expression of CD44 and CD133 was assessed on CD45⁻ cells to detect the circulating cancer stem cells (CSCs).

Table 1. Laboratory features, percentages of circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in HCC patients and controlsTable Footnote^a.

Download CSV Display Table

Table 2. Laboratory features of patients groups based on hepatic focal lesionsTable Footnote^a.

Download CSV Display Table

Table 3. Correlations between circulating HSCs, EPCs and CSCs in hepatocellular carcinoma patients and some laboratory parametersTable Footnote^a.

Download CSV Display Table

Supplemental material

Supplemental Material

Download MS Word (3.6 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis

Table 1. Laboratory features, percentages of circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in HCC patients and controlsTable Footnote^a.

Table 2. Laboratory features of patients groups based on hepatic focal lesionsTable Footnote^a.

Table 3. Correlations between circulating HSCs, EPCs and CSCs in hepatocellular carcinoma patients and some laboratory parametersTable Footnote^a.

Supplemental Material

Related Research Data

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis

Figures & data

Table 1. Laboratory features, percentages of circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in HCC patients and controlsTable Footnotea.

Table 2. Laboratory features of patients groups based on hepatic focal lesionsTable Footnotea.

Table 3. Correlations between circulating HSCs, EPCs and CSCs in hepatocellular carcinoma patients and some laboratory parametersTable Footnotea.

Supplemental Material

Reprints and Corporate Permissions

Academic Permissions

Related Research Data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Table 1. Laboratory features, percentages of circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in HCC patients and controlsTable Footnote^a.

Table 2. Laboratory features of patients groups based on hepatic focal lesionsTable Footnote^a.

Table 3. Correlations between circulating HSCs, EPCs and CSCs in hepatocellular carcinoma patients and some laboratory parametersTable Footnote^a.